CranioSense key facts
- Manufacturer of medical devices intended to unlock the hidden parameters of brain health by enabling on-demand neurological insight.
- It has raised $7.0M.
- Notable investors include Techstars, MassChallenge, MedTech Innovator, Texas Medical Center, Innovation Works — 16 tracked in total.
- Status: Privately Held (backing).
Who backs CranioSense
16+Membership and data by Private Market View
- ·The complete investor list: 16 names
- ·Watch CranioSense: the Monday email on marks, rounds and moves
CranioSense funding rounds
No funding rounds for CranioSense are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
CranioSense investors
16 investors are on record for CranioSense, including Techstars, MassChallenge, MedTech Innovator and Texas Medical Center. By type, the record holds 4 venture capital firms and 1 angel investor.
About CranioSense
Manufacturer of medical devices intended to unlock the hidden parameters of brain health by enabling on-demand neurological insight. The company offers noninvasive medical devices for initial diagnosis and continuous monitoring of intracranial hypertension, the point at which ICP becomes clinically unacceptable, enabling healthcare professionals with treatment across the neurological care spectrum.
- Sector
- Healthcare
- HQ
- Bedford, MA, United States
- Founded
- 2022
- Employees
- 6
- Website
- craniosense.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
CranioSense doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.